Biovista
PrivateLast Round
Grant
Mar 6, 2012
Total Funding Raised
$500,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Biovista is a biotechnology company that has developed an artificial intelligence-based platform intended to deliver custom drug repositioning, drug de-risking, and clinical hold services for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts, Subscription SaaS, Freemium, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biovista Comparables
Compare Biovista with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delta4 | 90% | |
| Purposeful | 84% | |
| Healx | 80% |
Biovista Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2012 | ||||
| Grant | May 5, 2011 |
Key People
Founding team and executive leadership
Biovista Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Solve ME/CFS Initiative | Grant |
| European Union Seventh Framework Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 30% MoM.
- Jun 25, 2026
Monthly visitors increased 123% MoM, reaching 4.8K.
Recent news
Latest coverage and updates
- launchesJul 6, 2026
Biovista Inc. launches Drug Combination Detection.
Biovista Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biovista's valuation, stock price, and market status.
Is Biovista a public or private company?
Biovista is a private company.
What is the current stock price of Biovista?
Biovista is a private company with no public stock price. No recent secondary market data is available.
How much is Biovista worth (valuation)?
Valuation information for Biovista is not publicly available.
Can I buy Biovista stock?
Biovista shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biovista's last funding round?
Biovista's most recent funding round was Grant on March 6, 2012.
Who are the main investors in Biovista?
Key investors in Biovista include Solve ME/CFS Initiative, European Union's Framework Programme 7.
Will Biovista IPO soon?
No public IPO plans have been announced for Biovista.
How can I track Biovista secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biovista's secondary market activity and sign up for updates.